/VTIAF
VTIAF Stock - FamiCord AG
Healthcare|Medical - Care FacilitiesOTC
$6.38+0.00%
+$0.00 (+0.00%) • Dec 19
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.60
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.91
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $7.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VTIAF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.31 – $6.44
TARGET (TP)$7.33
STOP LOSS$5.87
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.73
52W High$7.00
52W Low$4.57
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $82.18M | $77.06M | $68.94M | $28.42M | $20.07M |
| Gross Profit | $20.65M | $28.24M | $2.73M | $12.44M | $11.66M |
| Gross Margin | 25.1% | 36.7% | 4.0% | 43.8% | 58.1% |
| Operating Income | $-9,258,000 | $-3,120,000 | $-27,283,000 | $-3,071,000 | $2.38M |
| Net Income | $-12,136,000 | $-1,865,000 | $-27,087,000 | $-3,667,000 | $1.45M |
| Net Margin | -14.8% | -2.4% | -39.3% | -12.9% | 7.2% |
| EPS | $-0.70 | $-0.12 | $-1.71 | $-0.63 | $0.35 |
Company Overview
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VTIAFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.08
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 26, 2026 | — | — | — | — |
Q4 2025 | Nov 21, 2025 | — | $0.08 | — | — |
Q3 2025 | Aug 27, 2025 | — | $0.05 | — | — |
Q2 2025 | May 28, 2025 | — | $-0.04 | — | — |
Q2 2025 | Apr 30, 2025 | — | $-0.79 | — | — |
Q4 2024 | Nov 22, 2024 | — | $0.07 | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.09 | — | — |
Q2 2024 | May 31, 2024 | — | $-0.05 | — | — |
Q1 2024 | Jan 31, 2024 | — | $0.23 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.11 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.08 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.20 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-1.32 | — | — |
Q4 2022 | Nov 15, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 30, 2022 | — | $-0.31 | — | — |
Q2 2022 | May 2, 2022 | — | $-0.20 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.30 | — | — |
Q4 2021 | Nov 11, 2021 | — | $0.13 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 31, 2021 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about VTIAF
What is VTIAF's current stock price?
FamiCord AG (VTIAF) is currently trading at $6.38 per share. The stock has moved +0.00% today.
What is the analyst price target for VTIAF?
No analyst price targets are currently available for this stock.
What sector is FamiCord AG in?
FamiCord AG operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the OTC exchange.
What is VTIAF's market cap?
FamiCord AG has a market capitalization of $0.11 billion, making it a small-cap company.
Does VTIAF pay dividends?
No, FamiCord AG does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorHLTRF
HLS Therapeutics Inc.
$3.42
Mkt Cap: $0.1B
HOFBF
Hofseth BioCare ASA
$0.17
Mkt Cap: $0.1B
JUSHF
Jushi Holdings Inc.
$0.60
Mkt Cap: $0.1B
KNTPF
Kintor Pharmaceutical Limited
$0.22
Mkt Cap: $0.1B
LDXHF
Lumos Diagnostics Holdings Limited
$0.17
Mkt Cap: $0.1B
POLBF
Poolbeg Pharma PLC
$0.04
Mkt Cap: $0.0B
RCEL
AVITA Medical, Inc.
$3.46
Mkt Cap: $0.1B
SNZZF
Senzime AB (publ)
$0.45
Mkt Cap: $0.1B
TOKIF
Optima Medical Innovations Corp.
$0.01
Mkt Cap: $0.1B
VMTHF
Venus Medtech (Hangzhou) Inc.
$0.27
Mkt Cap: $0.1B
Explore stocks similar to VTIAF for comparison